Old Web
English
Sign In
Acemap
>
authorDetail
>
Mahmoud Abouraya
Mahmoud Abouraya
University of Wisconsin-Madison
Cytochrome-B(5) Reductase
Cytochrome b5 reductase
Pharmacology
Hydroxylamine
Toxicity
4
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.
2012
Pharmacogenetics and Genomics
James C. Sacco
Mahmoud Abouraya
Alison A. Motsinger-Reif
Steven H. Yale
Catherine A. McCarty
Lauren A. Trepanier
Show All
Source
Cite
Save
Citations (15)
Dapsone‐Associated Methemoglobinemia in a Patient With Slow NAT2*5B Haplotype and Impaired Cytochrome b5 Reductase Activity
2012
The Journal of Clinical Pharmacology
Mahmoud Abouraya
James C. Sacco
Kristie Hayes
Sajeve Samuel Thomas
Craig S. Kitchens
Lauren A. Trepanier
Show All
Source
Cite
Save
Citations (7)
Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis
2011
British Journal of Clinical Pharmacology
Mahmoud Abouraya
James C. Sacco
Brad S. Kahl
Lauren A. Trepanier
Show All
Source
Cite
Save
Citations (4)
Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine
2010
Archives of Toxicology
Sachin Bhusari
Mahmoud Abouraya
Marcia L. Padilla
Marie E. Pinkerton
Nicholas J. Drescher
James C. Sacco
Lauren A. Trepanier
Show All
Source
Cite
Save
Citations (6)
1